 | Up a level |
Journal Article
Broeckelmann, Paul J., Zagadailov, Erin A., Corman, Shelby L., Chirikov, Viktor, Johnson, Courtney, Macahilig, Cynthia, Seal, Brian, Dalal, Mehul R. and Illidge, Tim (2017). Brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma who are Ineligible for autologous stem cell transplant: A Germany and United Kingdom retrospective study. Eur. J. Haematol., 99 (6). S. 553 - 559. HOBOKEN: WILEY. ISSN 1600-0609
Zagadailov, Erin A., Corman, Shelby, Chirikov, Viktor, Johnson, Courtney, Macahilig, Cynthia, Seal, Brian, Dalal, Mehul R., Broeckelmann, Paul J. and Illidge, Tim (2018). Real-world effectiveness of brentuximab vedotin versus physicians' choice chemotherapy in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantation in the United Kingdom and Germany. Leuk. Lymphoma, 59 (6). S. 1413 - 1420. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403